I want my family to understand our shared cancer risks, but I sometimes struggle to face the painful reality of the disease ...

Detailed price information for Edible Garden Ag Inc (EDBL-Q) from The Globe and Mail including charting and trades.

Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...

Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; ...

After Plattekill Supervisor Dean DePew welcomed everyone to this year’s Memorial Day ceremony at the town park, veterans ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Verastem Oncology jumps 22% on FDA nod for Avmapki Fakzynja, the first approved KRAS-mutant LGSOC therapy, with strong early data in a pancreatic cancer study.

Many are busy filling out their KRAs (Key Result Areas) and eagerly awaiting promotions, designation changes, or a 30-40% ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...

GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles ...